MIRA Pharmaceuticals Statistics
Total Valuation
MIRA has a market cap or net worth of $32.69 million. The enterprise value is $31.96 million.
Important Dates
The next estimated earnings date is Friday, November 14, 2025, after market close.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRA has 20.82 million shares outstanding. The number of shares has increased by 14.16% in one year.
| Current Share Class | 20.82M |
| Shares Outstanding | 20.82M |
| Shares Change (YoY) | +14.16% |
| Shares Change (QoQ) | +2.05% |
| Owned by Insiders (%) | 21.09% |
| Owned by Institutions (%) | 4.95% |
| Float | 13.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 47.90 |
| P/TBV Ratio | 57.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.79
| Current Ratio | 2.79 |
| Quick Ratio | 2.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -556.87% and return on invested capital (ROIC) is -352.78%.
| Return on Equity (ROE) | -556.87% |
| Return on Assets (ROA) | -253.31% |
| Return on Invested Capital (ROIC) | -352.78% |
| Return on Capital Employed (ROCE) | -1,381.17% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.59M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.37% in the last 52 weeks. The beta is 1.75, so MIRA's price volatility has been higher than the market average.
| Beta (5Y) | 1.75 |
| 52-Week Price Change | -17.37% |
| 50-Day Moving Average | 1.43 |
| 200-Day Moving Average | 1.28 |
| Relative Strength Index (RSI) | 52.96 |
| Average Volume (20 Days) | 8,900,376 |
Short Selling Information
The latest short interest is 277,187, so 1.33% of the outstanding shares have been sold short.
| Short Interest | 277,187 |
| Short Previous Month | 247,361 |
| Short % of Shares Out | 1.33% |
| Short % of Float | 2.00% |
| Short Ratio (days to cover) | 0.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.87M |
| Pretax Income | -7.77M |
| Net Income | -7.77M |
| EBITDA | n/a |
| EBIT | -7.87M |
| Earnings Per Share (EPS) | -$0.46 |
Full Income StatementBalance Sheet
The company has $730,475 in cash and n/a in debt, giving a net cash position of $730,475 or $0.04 per share.
| Cash & Cash Equivalents | 730,475 |
| Total Debt | n/a |
| Net Cash | 730,475 |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 569,859 |
| Book Value Per Share | 0.03 |
| Working Capital | 534,420 |
Full Balance SheetCash Flow
| Operating Cash Flow | -6.08M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
